Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.680
-0.400-6.58%
Volume:4.88M
Turnover:28.37M
Market Cap:9.07B
PE:-18.05
High:5.990
Open:5.990
Low:5.680
Close:6.080
52wk High:11.190
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.40
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.00
PE(LYR):-18.05
PS:18.25

Loading ...

CSTONE PHARMA-B 2025年净亏损达4.37亿元,创新管线投入加速推进

Bulletin Express
·
Apr 27

CStone Pharmaceuticals publishes 2025 annual report

Reuters
·
Apr 27

Stock Track | CStone Pharma-B Plummets 5.90% Intraday on Share Placement Dilution Concerns

Stock Track
·
Apr 24

CStone Pharmaceuticals raises HK$1.05 billion through placing of 118 million new shares, expanding capital base by 7.40%

Bulletin Express
·
Apr 22

CSTONE PHARMA-B Allots 118 Million New Shares Under Placement Agreement

Stock News
·
Apr 22

CStone files HKEX next-day return for 118,000,000-share issue at HKD 8.97

Reuters
·
Apr 22

Stock Track | CSTONE PHARMA-B Soars 5.10% Intraday on Positive CS2009 Clinical Data for ASCO Presentation

Stock Track
·
Apr 22

CSTONE PHARMA-B Shares Surge Nearly 5% at Open, Set to Reveal Key CS2009 Clinical Milestones at 2026 ASCO Conference

Deep News
·
Apr 22

Key Clinical Milestones for CSTONE PHARMA-B's CS2009 to be Presented at ASCO Annual Meeting

Stock News
·
Apr 22

CStone to present updated CS2009 phase 1/2 NSCLC data at ASCO 2026

Reuters
·
Apr 22

HHLR Advisors Increases Stake in CStone Pharma by 26.2 Million Shares at HK$8.97 Each

Stock News
·
Apr 21

CStone Pharmaceuticals Showcases Preclinical Findings for Three Novel ADC Candidates at AACR Conference

Stock News
·
Apr 20

CStone showcases robust preclinical results for three proprietary ADCs at AACR 2026; IND filings slated for 2026

Bulletin Express
·
Apr 20

CStone plans Phase I CS5007-101 trial in advanced solid tumors after IND filing

Reuters
·
Apr 20

Stock Track | CStone Pharma-B Soars 5.05% Intraday on HK$1.05 Billion Placement to Fund Pipeline Development

Stock Track
·
Apr 16

CStone Pharmaceuticals-B Sees Over 4% Surge Following Proposed Placement to Raise HK$1.05 Billion

Stock News
·
Apr 16

CSTONE PHARMA-B Announces Placement of 118 Million Shares to Raise Approximately HK$1.053 Billion

Stock News
·
Apr 15

CStone Pharma to Raise HK$1.06 Billion via 118 Million-Share Placement at 6.95% Discount

Bulletin Express
·
Apr 15

CStone Pharmaceuticals - to Place Aggregate of 118 Mln Shares at HK$8.97 per Placing Share

THOMSON REUTERS
·
Apr 15

CStone Pharmaceuticals places 118,000,000 new shares at HK$8.97 each

Reuters
·
Apr 15